Band 4
Provided by Jan Juroška
Jan Juroška is a Partner in tthe Managing Partner of the Prague office, the head of the local and the co-head of the firm-wide M&A, Corporate and Private Equity service line. He has a particular focus on private equity and corporate finance.
Czech Bar Association
Czech
English
Provided by Chambers
Provided by Chambers
7 items provided by Kinstellar
Kinstellar advises Kemp Technologies on the acquisition of Flowmon
Kinstellar has successfully advised Kemp Technologies, the leader in powering always-on application experience, on its acquisition of Flowmon, a global network intelligence company.
Kinstellar advises Genesis Growth Equity Fund I on the acquisition of R2B2
Kinstellar has successfully advised Genesis Growth Equity Fund I on its acquisition of R2B2, a key player in programmatic advertising in the Czech Republic.
Kinstellar advises GLP, a leading global investment manager, on a EUR 1 billion multi-jurisdictional
Kinstellar has advised GLP, a leading global investment manager specialising in logistics, real estate, insurance and related technology investments, on the Czech, Slovak and Hungarian law aspects of its acquisition of Goodman Group’s Central and Eastern Europe logistics real real estate portfolio.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s., the Czech Republic, from the Cyrus Poonawalla Group.
Kinstellar advises Genesis Private Equity Fund III on the acquisition of the largest Czech call cent
Kinstellar has successfully advised Genesis Private Equity Fund III (GPEF III) on its acquisition, from Karel Komárek's KKCG investment group, of the largest operator of contact centres in the Czech Republic.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility in the Czech Repub
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s. from the Cyrus Poonawalla Group.
Kinstellar advises Kemp Technologies on the acquisition of Flowmon
Kinstellar has successfully advised Kemp Technologies, the leader in powering always-on application experience, on its acquisition of Flowmon, a global network intelligence company.
Kinstellar advises Genesis Growth Equity Fund I on the acquisition of R2B2
Kinstellar has successfully advised Genesis Growth Equity Fund I on its acquisition of R2B2, a key player in programmatic advertising in the Czech Republic.
Kinstellar advises GLP, a leading global investment manager, on a EUR 1 billion multi-jurisdictional
Kinstellar has advised GLP, a leading global investment manager specialising in logistics, real estate, insurance and related technology investments, on the Czech, Slovak and Hungarian law aspects of its acquisition of Goodman Group’s Central and Eastern Europe logistics real real estate portfolio.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s., the Czech Republic, from the Cyrus Poonawalla Group.
Kinstellar advises Genesis Private Equity Fund III on the acquisition of the largest Czech call cent
Kinstellar has successfully advised Genesis Private Equity Fund III (GPEF III) on its acquisition, from Karel Komárek's KKCG investment group, of the largest operator of contact centres in the Czech Republic.
Kinstellar advises Novavax on its acquisition of a vaccine manufacturing facility in the Czech Repub
Kinstellar has successfully advised US-based Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, on its acquisition of Praha Vaccines a.s. from the Cyrus Poonawalla Group.
